These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 30603350)

  • 1. Renal Function During an Open-Label Prospective Observational Trial of Sitagliptin in Patients With Diabetes: A Sub-Analysis of the JAMP Study.
    Tomonaga O; Sakura H; Hashimoto N; Sasamoto K; Ohashi H; Hasumi S; Ujihara N; Kasahara T; Nunome H; Honda M; Iwamoto Y;
    J Clin Med Res; 2018 Jan; 10(1):32-40. PubMed ID: 29238432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adding of Sitagliptin on Insulin Therapy Effectively and Safely Reduces a Hemoglobin A1c Level and Glucose Fluctuation in Japanese Patients with Type 2 Diabetes.
    Tajiri Y; Kawano S; Hirao S; Oshige T; Iwata S; Ono Y; Inada C; Akashi T; Hayashi H; Sato Y; Tojikubo M; Yamada K
    Int Sch Res Notices; 2014; 2014():639489. PubMed ID: 27419209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of sitagliptin treatment in older adults with moderately controlled type 2 diabetes: the STREAM study.
    Nagao M; Sasaki J; Sugihara H; Tanimura-Inagaki K; Harada T; Sakuma I; Oikawa S;
    Sci Rep; 2023 Jan; 13(1):134. PubMed ID: 36599895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of sitagliptin in elderly patients with type 2 diabetes mellitus and comparison of hypoglycemic action of concomitant medications: a subanalysis of the JAMP study.
    Ujihara N; Sakura H; Hashimoto N; Sasamoto K; Ohashi H; Hasumi S; Kasahara T; Tomonaga O; Nunome H; Honda M; Iwamoto Y;
    Diabetol Int; 2018 Feb; 9(1):56-65. PubMed ID: 30603350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors involved in decreasing the therapeutic effect of sitagliptin: a subanalysis of the JAMP study.
    Nunome H; Sakura H; Hashimoto N; Sasamoto K; Ohashi H; Hasumi S; Ujihara N; Kasahara T; Tomonaga O; Honda M; Iwamoto Y;
    Diabetol Int; 2018 Jul; 9(3):158-167. PubMed ID: 30603363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and Safety of Adding Sitagliptin in Type 2 Diabetes Patients on Insulin: Age-Stratified Comparison at One Year in the ASSIST-K Study.
    Takai M; Ishikawa M; Maeda H; Kanamori A; Kubota A; Amemiya H; Iizuka T; Iemitsu K; Iwasaki T; Uehara G; Umezawa S; Obana M; Kaneshige H; Kaneshiro M; Kawata T; Sasai N; Saito T; Takuma T; Takeda H; Tanaka K; Nakajima S; Hoshino K; Honda S; Machimura H; Matoba K; Minagawa F; Minami N; Miyairi Y; Mokubo A; Motomiya T; Waseda M; Miyakawa M; Terauchi Y; Tanaka Y; Matsuba I
    J Clin Med Res; 2019 May; 11(5):311-320. PubMed ID: 31019624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erratum to: Efficacy and safety of sitagliptin in elderly patients with type 2 diabetes mellitus and comparison of hypoglycemic action of concomitant medications: a subanalysis of the JAMP study.
    Ujihara N; Sakura H; Hashimoto N; Sasamoto K; Ohashi H; Hasumi S; Kasahara T; Tomonaga O; Nunome H; Honda M; Iwamoto Y;
    Diabetol Int; 2018 Feb; 9(1):66-67. PubMed ID: 30605174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of sitagliptin monotherapy and combination therapy in Japanese type 2 diabetes patients.
    Kubota A; Maeda H; Kanamori A; Matoba K; Jin Y; Minagawa F; Obana M; Iemitsu K; Ito S; Amamiya H; Kaneshiro M; Takai M; Kaneshige H; Hoshino K; Ishikawa M; Minami N; Takuma T; Sasai N; Aoyagi S; Kawata T; Mokubo A; Takeda H; Honda S; Machimura H; Motomiya T; Waseda M; Naka Y; Tanaka Y; Terauchi Y; Matsuba I
    J Diabetes Investig; 2012 Dec; 3(6):503-9. PubMed ID: 24843615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of vildagliptin, Saxagliptin or Sitagliptin as add-on therapy in Chinese patients with type 2 diabetes inadequately controlled with dual combination of traditional oral hypoglycemic agents.
    Li CJ; Liu XJ; Bai L; Yu Q; Zhang QM; Yu P; Yu DM
    Diabetol Metab Syndr; 2014; 6():69. PubMed ID: 24917890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of sitagliptin on blood glucose control in patients with type 2 diabetes mellitus who are treatment naive or poorly responsive to existing antidiabetic drugs: the JAMP study.
    Sakura H; Hashimoto N; Sasamoto K; Ohashi H; Hasumi S; Ujihara N; Kasahara T; Tomonaga O; Nunome H; Honda M; Iwamoto Y;
    BMC Endocr Disord; 2016 Dec; 16(1):70. PubMed ID: 27905912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term Efficacy and Safety of Sitagliptin in Elderly Patients with Type 2 Diabetes Mellitus.
    Tada Y; Kanazawa I; Notsu M; Tanaka K; Kiyohara N; Sasaki M; Sugimoto T
    Intern Med; 2016; 55(10):1275-8. PubMed ID: 27181532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [THE FACTORS OF THE PROGRESSION OF METABOLIC DISORDERS IN THE PANCREAS IN PATIENTS WITH ASSOCIATED CLINICAL VARIANTS OF THE CHRONIC PANCREATITIS AND TYPE 2 DIABETES MELLITUS].
    Zhuravlyova LV; Shekhovtsova YO
    Lik Sprava; 2015; (5-6):46-51. PubMed ID: 27089715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-year assessment of the efficacy and safety of sitagliptin in elderly patients with type 2 diabetes: Post hoc analysis of the ASSET-K study.
    Umezawa S; Kubota A; Maeda H; Kanamori A; Matoba K; Jin Y; Minagawa F; Obana M; Iemitsu K; Ito S; Amamiya H; Kaneshiro M; Takai M; Kaneshige H; Hoshino K; Ishikawa M; Minami N; Takuma T; Sasai N; Aoyagi S; Kawata T; Mokubo A; Miyairi Y; Takeda H; Honda S; Machimura H; Motomiya T; Waseda M; Naka Y; Tanaka Y; Terauchi Y; Matsuba I
    BMC Endocr Disord; 2015 Jul; 15():34. PubMed ID: 26137940
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.